# Nurix Therapeutics, Inc. > Alpha governed public record. Unknown, unavailable, and unpublished values are never inferred as zero. ## Record | Field | Value | | --- | --- | | Representation | alpha-profile-markdown-v4 | | Protocol | Alpha Governance Facts Protocol 0.1 | | Schema | alpha.governance.entity.public.v1 | | Record version | public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce | | Governance record representation | alpha-governance-record-v2 | | Canonical entity | alpha:company:60b3f0b6-9831-4656-98a1-c0b90831677e | | Entity type | Company | | Canonical URL | https://registry.alpha.ac/companies/nurix-therapeutics-inc | | Publication | PUBLISHED | | Verification | source_reported | | Verification schema | alpha-verification-states-v1 | | Ownership | unclaimed | | Published claims | 22 | | Claims under review | 1 | | Evidence records | 3 | | Conflicts | 0 | | Conflicts in internal review | 0 | | Observed | 2026-10-22T04:45:53.856826+00:00 | | Last reviewed | 2026-10-22T04:45:53.856826+00:00 | ## Identity - Legal name: Nurix Therapeutics, Inc. - Display name: Nurix Therapeutics, Inc. ## Alpha Governance Record | Field | Value | | --- | --- | | Governance Record schema | alpha-governance-record-v2 | | Ontology | alpha-governance-ontology-v1 | | Record version | public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce | | As of | 2026-10-22T22:23:39.958826+00:00 | | Completeness | 0.409 | | Record Quality | 0.829 | | Directors | 14 | | Committees | 1 | | Governance events | 8 | | Entity class | public_company | ## Section coverage | Section | State | | --- | --- | | identity | PUBLISHED | | corporate_structure | NOT_REVIEWED | | board | PUBLISHED | | committees | PUBLISHED | | leadership | PUBLISHED | | ownership | NOT_REVIEWED | | financials | NOT_REVIEWED | | capital_structure | PUBLISHED | | compensation | NOT_REVIEWED | | governance | NOT_REVIEWED | | shareholder_governance | NOT_REVIEWED | | audit | NOT_REVIEWED | | legal | NOT_REVIEWED | | risk | NOT_REVIEWED | | cyber | NOT_REVIEWED | | ai_governance | NOT_REVIEWED | | agent_governance | RESTRICTED | | markets_external | NOT_REVIEWED | | events | PUBLISHED | | relationships | PUBLISHED | | assessments | PUBLISHED | | evidence | PUBLISHED | ## Board - Arthur T. Sands: Director. Status: current. Independent: NOT_PUBLISHED. Since: 2026-03-27. claim_id=alpha:claim:company:60b3f0b6-9831-4656-98a1-c0b90831677e:leadership_role:6 - David L. Lacey: Director. Status: current. Independent: NOT_PUBLISHED. Since: 2016-01-01. claim_id=alpha:claim:company:60b3f0b6-9831-4656-98a1-c0b90831677e:leadership_role:8 - Edward C. Saltzman: Director. Status: current. Independent: NOT_PUBLISHED. Since: 2022-01-01. claim_id=alpha:claim:company:60b3f0b6-9831-4656-98a1-c0b90831677e:leadership_role:10 - Gwenn M. Hansen: Director. Status: current. Independent: NOT_PUBLISHED. Since: 2026-03-27. claim_id=alpha:claim:company:60b3f0b6-9831-4656-98a1-c0b90831677e:leadership_role:11 - Judith A. Reinsdorf: Director. Status: current. Independent: NOT_PUBLISHED. Since: 2021-01-01. claim_id=alpha:claim:company:60b3f0b6-9831-4656-98a1-c0b90831677e:leadership_role:12 - Julia P. Gregory: Director. Status: current. Independent: NOT_PUBLISHED. Since: 2025-01-01. claim_id=alpha:claim:company:60b3f0b6-9831-4656-98a1-c0b90831677e:leadership_role:14 - Paul M. Silva: Director. Status: current. Independent: NOT_PUBLISHED. Since: 2021-01-01. claim_id=alpha:claim:company:60b3f0b6-9831-4656-98a1-c0b90831677e:leadership_role:15 - Roger Dansey: Director. Status: current. Independent: NOT_PUBLISHED. Since: 2025-01-01. claim_id=alpha:claim:company:60b3f0b6-9831-4656-98a1-c0b90831677e:leadership_role:16 - Anil Kapur: Director. Status: unknown. Independent: true. Since: NOT_PUBLISHED. claim_id=alpha:claim:company:60b3f0b6-9831-4656-98a1-c0b90831677e:leadership_role:5 - Arthur T. Sands, M.D., Ph.D.: President, Chief Executive Officer and Director. Status: unknown. Independent: false. Since: NOT_PUBLISHED. Committees: Chief Executive Officer and Director (member). claim_id=alpha:claim:company:60b3f0b6-9831-4656-98a1-c0b90831677e:leadership_role:7 - David L. Lacey, M.D.: Director. Status: unknown. Independent: true. Since: NOT_PUBLISHED. claim_id=alpha:claim:company:60b3f0b6-9831-4656-98a1-c0b90831677e:leadership_role:9 - Judith A. Reinsdorf, J.D.: Director. Status: unknown. Independent: true. Since: NOT_PUBLISHED. claim_id=alpha:claim:company:60b3f0b6-9831-4656-98a1-c0b90831677e:leadership_role:13 - Roger Dansey, M.D.: Director. Status: unknown. Independent: true. Since: NOT_PUBLISHED. claim_id=alpha:claim:company:60b3f0b6-9831-4656-98a1-c0b90831677e:leadership_role:17 - Roy D. Baynes, MB.Bch., M.Med., Ph.D.: Director. Status: unknown. Independent: true. Since: NOT_PUBLISHED. claim_id=alpha:claim:company:60b3f0b6-9831-4656-98a1-c0b90831677e:leadership_role:18 ## Committees - Chief Executive Officer and Director (executive). Chair: NOT_PUBLISHED. Members: Arthur T. Sands, M.D., Ph.D. (member, unknown). committee_id=alpha:committee:nurix-therapeutics-inc:chief-executive-officer-and-director ## Executive leadership - Arthur T. Sands, M.D., Ph.D.: President and Chief Executive Officer [CEO]. Status: unknown. claim_id=alpha:claim:company:60b3f0b6-9831-4656-98a1-c0b90831677e:leadership_role:19 - Christine Ring, Ph.D., J.D.: Chief Legal Officer, Chief Compliance Officer and Secretary [GC]. Status: unknown. claim_id=alpha:claim:company:60b3f0b6-9831-4656-98a1-c0b90831677e:leadership_role:20 - Gwenn M. Hansen, Ph.D.: Chief Scientific Officer. Status: unknown. claim_id=alpha:claim:company:60b3f0b6-9831-4656-98a1-c0b90831677e:leadership_role:21 - Hans van Houte: Chief Financial Officer [CFO]. Status: unknown. claim_id=alpha:claim:company:60b3f0b6-9831-4656-98a1-c0b90831677e:leadership_role:22 ## Governance events - DIRECTOR_APPOINTED: Arthur T. Sands seat on Nurix Therapeutics, Inc., effective 2026-03-27. Effective: 2026-03-27. Detected: 2026-10-22T04:45:53.856826+00:00. event_id=alpha:event:transition:dg8n1t1afkasj - DIRECTOR_APPOINTED: Gwenn M. Hansen seat on Nurix Therapeutics, Inc., effective 2026-03-27. Effective: 2026-03-27. Detected: 2026-10-22T04:45:53.856826+00:00. event_id=alpha:event:transition:1c7uobjrmipot - DIRECTOR_APPOINTED: Julia P. Gregory seat on Nurix Therapeutics, Inc., effective 2025-01-01. Effective: 2025-01-01. Detected: 2026-10-22T04:45:53.856826+00:00. event_id=alpha:event:transition:1e38vmlr9r25d - DIRECTOR_APPOINTED: Roger Dansey seat on Nurix Therapeutics, Inc., effective 2025-01-01. Effective: 2025-01-01. Detected: 2026-10-22T04:45:53.856826+00:00. event_id=alpha:event:transition:1b6qz0b1l2d5uj - DIRECTOR_APPOINTED: Edward C. Saltzman seat on Nurix Therapeutics, Inc., effective 2022-01-01. Effective: 2022-01-01. Detected: 2026-10-22T04:45:53.856826+00:00. event_id=alpha:event:transition:1xy8hhum7zwj6 - DIRECTOR_APPOINTED: Judith A. Reinsdorf seat on Nurix Therapeutics, Inc., effective 2021-01-01. Effective: 2021-01-01. Detected: 2026-10-22T04:45:53.856826+00:00. event_id=alpha:event:transition:sncul51jujva7 - DIRECTOR_APPOINTED: Paul M. Silva seat on Nurix Therapeutics, Inc., effective 2021-01-01. Effective: 2021-01-01. Detected: 2026-10-22T04:45:53.856826+00:00. event_id=alpha:event:transition:15diqr2zuly7c - DIRECTOR_APPOINTED: David L. Lacey seat on Nurix Therapeutics, Inc., effective 2016-01-01. Effective: 2016-01-01. Detected: 2026-10-22T04:45:53.856826+00:00. event_id=alpha:event:transition:8nv9cc1f1qs ## Scoped resources - `alpha://company/nurix-therapeutics-inc` (contract): https://registry.alpha.ac/api/public/companies/nurix-therapeutics-inc?format=record - `alpha://company/nurix-therapeutics-inc/identity` (contract): https://registry.alpha.ac/api/public/companies/nurix-therapeutics-inc?format=record§ion=identity - `alpha://company/nurix-therapeutics-inc/corporate-structure` (contract): https://registry.alpha.ac/api/public/companies/nurix-therapeutics-inc?format=record§ion=corporate-structure - `alpha://company/nurix-therapeutics-inc/board` (contract): https://registry.alpha.ac/api/public/companies/nurix-therapeutics-inc?format=record§ion=board - `alpha://company/nurix-therapeutics-inc/committees` (contract): https://registry.alpha.ac/api/public/companies/nurix-therapeutics-inc?format=record§ion=committees - `alpha://company/nurix-therapeutics-inc/leadership` (contract): https://registry.alpha.ac/api/public/companies/nurix-therapeutics-inc?format=record§ion=leadership - `alpha://company/nurix-therapeutics-inc/ownership` (contract): https://registry.alpha.ac/api/public/companies/nurix-therapeutics-inc?format=record§ion=ownership - `alpha://company/nurix-therapeutics-inc/financials` (contract): https://registry.alpha.ac/api/public/companies/nurix-therapeutics-inc?format=record§ion=financials - `alpha://company/nurix-therapeutics-inc/capital-structure` (contract): https://registry.alpha.ac/api/public/companies/nurix-therapeutics-inc?format=record§ion=capital-structure - `alpha://company/nurix-therapeutics-inc/compensation` (contract): https://registry.alpha.ac/api/public/companies/nurix-therapeutics-inc?format=record§ion=compensation - `alpha://company/nurix-therapeutics-inc/governance` (contract): https://registry.alpha.ac/api/public/companies/nurix-therapeutics-inc?format=record§ion=governance - `alpha://company/nurix-therapeutics-inc/shareholder-governance` (contract): https://registry.alpha.ac/api/public/companies/nurix-therapeutics-inc?format=record§ion=shareholder-governance - `alpha://company/nurix-therapeutics-inc/audit` (contract): https://registry.alpha.ac/api/public/companies/nurix-therapeutics-inc?format=record§ion=audit - `alpha://company/nurix-therapeutics-inc/legal` (contract): https://registry.alpha.ac/api/public/companies/nurix-therapeutics-inc?format=record§ion=legal - `alpha://company/nurix-therapeutics-inc/risk` (contract): https://registry.alpha.ac/api/public/companies/nurix-therapeutics-inc?format=record§ion=risk - `alpha://company/nurix-therapeutics-inc/cyber` (contract): https://registry.alpha.ac/api/public/companies/nurix-therapeutics-inc?format=record§ion=cyber - `alpha://company/nurix-therapeutics-inc/ai-governance` (contract): https://registry.alpha.ac/api/public/companies/nurix-therapeutics-inc?format=record§ion=ai-governance - `alpha://company/nurix-therapeutics-inc/agents` (contract): https://registry.alpha.ac/api/public/companies/nurix-therapeutics-inc?format=record§ion=agents - `alpha://company/nurix-therapeutics-inc/ecosystem` (contract): https://registry.alpha.ac/api/public/companies/nurix-therapeutics-inc?format=record§ion=ecosystem - `alpha://company/nurix-therapeutics-inc/events` (contract): https://registry.alpha.ac/api/public/companies/nurix-therapeutics-inc?format=record§ion=events - `alpha://company/nurix-therapeutics-inc/relationships` (contract): https://registry.alpha.ac/api/public/companies/nurix-therapeutics-inc?format=record§ion=relationships - `alpha://company/nurix-therapeutics-inc/assessments` (contract): https://registry.alpha.ac/api/public/companies/nurix-therapeutics-inc?format=record§ion=assessments - `alpha://company/nurix-therapeutics-inc/evidence` (contract): https://registry.alpha.ac/api/public/companies/nurix-therapeutics-inc?format=record§ion=evidence ## Role modules - NOT_ASSERTED ## Attention - NO_RECORDS_FOUND ## Committee data - NO_RECORDS_FOUND ## Leadership - Anil Kapur: Director. Claim: alpha:claim:company:60b3f0b6-9831-4656-98a1-c0b90831677e:leadership_role:5. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:f3cb7f16d502d09f0b23addda6419e07affd161137136117723019adca74d9c4. - Arthur T. Sands: Director. Claim: alpha:claim:company:60b3f0b6-9831-4656-98a1-c0b90831677e:leadership_role:6. Valid from: 2026-03-27. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:c5768a60e709689bde64e57ce36891594c5ca83f9150fbeafb1e85f884bd56ec. - Arthur T. Sands, M.D., Ph.D.: President, Chief Executive Officer and Director. Claim: alpha:claim:company:60b3f0b6-9831-4656-98a1-c0b90831677e:leadership_role:7. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:f3cb7f16d502d09f0b23addda6419e07affd161137136117723019adca74d9c4. - David L. Lacey: Director. Claim: alpha:claim:company:60b3f0b6-9831-4656-98a1-c0b90831677e:leadership_role:8. Valid from: 2016-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:c5768a60e709689bde64e57ce36891594c5ca83f9150fbeafb1e85f884bd56ec. - David L. Lacey, M.D.: Director. Claim: alpha:claim:company:60b3f0b6-9831-4656-98a1-c0b90831677e:leadership_role:9. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:f3cb7f16d502d09f0b23addda6419e07affd161137136117723019adca74d9c4. - Edward C. Saltzman: Director. Claim: alpha:claim:company:60b3f0b6-9831-4656-98a1-c0b90831677e:leadership_role:10. Valid from: 2022-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:c5768a60e709689bde64e57ce36891594c5ca83f9150fbeafb1e85f884bd56ec. - Gwenn M. Hansen: Director. Claim: alpha:claim:company:60b3f0b6-9831-4656-98a1-c0b90831677e:leadership_role:11. Valid from: 2026-03-27. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:c5768a60e709689bde64e57ce36891594c5ca83f9150fbeafb1e85f884bd56ec. - Judith A. Reinsdorf: Director. Claim: alpha:claim:company:60b3f0b6-9831-4656-98a1-c0b90831677e:leadership_role:12. Valid from: 2021-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:c5768a60e709689bde64e57ce36891594c5ca83f9150fbeafb1e85f884bd56ec. - Judith A. Reinsdorf, J.D.: Director. Claim: alpha:claim:company:60b3f0b6-9831-4656-98a1-c0b90831677e:leadership_role:13. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:f3cb7f16d502d09f0b23addda6419e07affd161137136117723019adca74d9c4. - Julia P. Gregory: Director. Claim: alpha:claim:company:60b3f0b6-9831-4656-98a1-c0b90831677e:leadership_role:14. Valid from: 2025-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:c5768a60e709689bde64e57ce36891594c5ca83f9150fbeafb1e85f884bd56ec. - Paul M. Silva: Director. Claim: alpha:claim:company:60b3f0b6-9831-4656-98a1-c0b90831677e:leadership_role:15. Valid from: 2021-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:c5768a60e709689bde64e57ce36891594c5ca83f9150fbeafb1e85f884bd56ec. - Roger Dansey: Director. Claim: alpha:claim:company:60b3f0b6-9831-4656-98a1-c0b90831677e:leadership_role:16. Valid from: 2025-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:c5768a60e709689bde64e57ce36891594c5ca83f9150fbeafb1e85f884bd56ec. - Roger Dansey, M.D.: Director. Claim: alpha:claim:company:60b3f0b6-9831-4656-98a1-c0b90831677e:leadership_role:17. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:f3cb7f16d502d09f0b23addda6419e07affd161137136117723019adca74d9c4. - Roy D. Baynes, MB.Bch., M.Med., Ph.D.: Director. Claim: alpha:claim:company:60b3f0b6-9831-4656-98a1-c0b90831677e:leadership_role:18. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:f3cb7f16d502d09f0b23addda6419e07affd161137136117723019adca74d9c4. - Arthur T. Sands, M.D., Ph.D.: President and Chief Executive Officer. Claim: alpha:claim:company:60b3f0b6-9831-4656-98a1-c0b90831677e:leadership_role:19. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:f3cb7f16d502d09f0b23addda6419e07affd161137136117723019adca74d9c4. - Christine Ring, Ph.D., J.D.: Chief Legal Officer, Chief Compliance Officer and Secretary. Claim: alpha:claim:company:60b3f0b6-9831-4656-98a1-c0b90831677e:leadership_role:20. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:f3cb7f16d502d09f0b23addda6419e07affd161137136117723019adca74d9c4. - Gwenn M. Hansen, Ph.D.: Chief Scientific Officer. Claim: alpha:claim:company:60b3f0b6-9831-4656-98a1-c0b90831677e:leadership_role:21. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:f3cb7f16d502d09f0b23addda6419e07affd161137136117723019adca74d9c4. - Hans van Houte: Chief Financial Officer. Claim: alpha:claim:company:60b3f0b6-9831-4656-98a1-c0b90831677e:leadership_role:22. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:f3cb7f16d502d09f0b23addda6419e07affd161137136117723019adca74d9c4. ## Roles - PUBLISHED ## Governance - NOT_ASSERTED ## Board committees - PUBLISHED ## Financials - NOT_ASSERTED ## Workforce - NOT_ASSERTED ## Market and index context - PUBLISHED ## Legal Name - Nurix Therapeutics, Inc.. Claim: alpha:claim:company:60b3f0b6-9831-4656-98a1-c0b90831677e:legal_name:1. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:c54774b884c3cdaf3bfab33c0fbeb9990c12d82ab76af607fad5ba3be6683426. ## Entity Status - Public listing published. Claim: alpha:claim:company:60b3f0b6-9831-4656-98a1-c0b90831677e:entity_status:3. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:c54774b884c3cdaf3bfab33c0fbeb9990c12d82ab76af607fad5ba3be6683426. ## Published Fact - US. Claim: alpha:claim:company:60b3f0b6-9831-4656-98a1-c0b90831677e:published_fact:4. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:c54774b884c3cdaf3bfab33c0fbeb9990c12d82ab76af607fad5ba3be6683426. ## Security Listing - NRIX (NASDAQ). Claim: alpha:claim:company:60b3f0b6-9831-4656-98a1-c0b90831677e:security_listing:23. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:c54774b884c3cdaf3bfab33c0fbeb9990c12d82ab76af607fad5ba3be6683426. ## Coverage states | Field | Value | | --- | --- | | Identity | PUBLISHED | | Business | PUBLISHED | | Leadership | PUBLISHED | | Board and committees | PUBLISHED | | Governance | NOT_ASSERTED | | Financials | NOT_ASSERTED | | Workforce | NOT_ASSERTED | | Ownership | NOT_ASSERTED | | Ratings | NOT_PUBLISHED | | Market and index context | PUBLISHED | ## Public sources - alpha:projection-evidence:c54774b884c3cdaf3bfab33c0fbeb9990c12d82ab76af607fad5ba3be6683426: [Alpha canonical company public projection](https://www.alpha.ac/api/public/companies/nurix-therapeutics-inc). - alpha:projection-evidence:document:f3cb7f16d502d09f0b23addda6419e07affd161137136117723019adca74d9c4: [SEC DEF 14A 0001140361-26-011492](https://www.sec.gov/Archives/edgar/data/1549595/000114036126011492/ny20064945x1_def14a.htm). - alpha:projection-evidence:document:c5768a60e709689bde64e57ce36891594c5ca83f9150fbeafb1e85f884bd56ec: [DEF 14A ny20064945x1_def14a.htm](https://www.sec.gov/Archives/edgar/data/1549595/000114036126011492/ny20064945x1_def14a.htm). ## Rights | Field | Value | | --- | --- | | public_retrieval | allowed | | agent_retrieval | allowed | | redistribution | not_granted | | model_training | not_granted | | commercial_use | not_specified | | relationship_pathfinding | not_granted | | direct_contact | not_granted | ## Limitations - Absence of a leadership role, committee, or disclosure is not evidence that it does not exist. - Only explicitly published canonical company identity and current confirmed public roles are included. - Absence of a board, committee, executive, listing, or claim is not evidence that it does not exist. - Public retrieval does not grant redistribution, model-training, direct-contact, or relationship-pathfinding rights. - This Company Profile is an identity and evidence record, not an Alpha rating. ## Alternate representations - [Canonical profile](https://registry.alpha.ac/companies/nurix-therapeutics-inc) - [Public Markdown](https://registry.alpha.ac/companies/nurix-therapeutics-inc.md) - [Public JSON](https://registry.alpha.ac/api/public/companies/nurix-therapeutics-inc?format=record) - [JSON-LD](https://registry.alpha.ac/api/public/companies/nurix-therapeutics-inc?format=jsonld) - MCP resource: `alpha://companies/nurix-therapeutics-inc` at https://mcp.alpha.ac/mcp ## Connected governance records Only explicitly published, rights-cleared records. Missing records do not establish absence, safety, or complete coverage. ## Critical-risk oversight Snapshot as of 2026-10-22T22:23:39.652969+00:00; recorded 2026-10-22T22:23:39.652969+00:00. Every published assignment for this snapshot is listed. Only explicitly reviewed, rights-cleared assignments in effect on the as-of date, in the company's own wording. An assignment shows where oversight is placed, not whether it is effective. Missing records do not establish absence.